Leukotape K is an elastic kinesiology tape which has been successfully used for many years to relieve pain, treat swelling and discomfort and improve function for athletes and patients in both daily practice and in hospitals. Leukotape K is sold in more than 90 countries around the world.
Essity is investing in a new fully automated production line for Leukotape K at its Vibraye, France site.
This expansion will quintuple production capacity to meet rising global demand for the elastic kinesiology tape used in pain relief and injury recovery.
Essity, the third-largest player in non-invasive orthopedic products, also produces other medical solutions.
The new fully automated production line is located at Essity’s site in Vibraye, France and will fivefold the production capacity of Leukotape K. The investment amounted to €1 million (~$1.05 million).
“We are proud to announce that we are expanding the production at our Vibraye site, dedicated to producing high-quality medical solutions. Leukotape K enables recovery from injury and is managing pain during demanding sports for amateur and professional athletes around the world,” said Ulrika Kolsrud, president health & medical, Essity.
The production facility in France can annually produce more than 10 million m2 (or about 1,400 football fields) of elastic adhesive tape under Essity’s brands Actimove, Leukoplast and Tensoplast, the company said in a press release.
Essity is the world’s third largest player within non-invasive orthopedic products. Solutions are offered for skeletal, muscular and joint injuries as well as for chronic conditions such as arthritis. The product assortment includes products such as casts, splints, braces support products and athletic tapes.
Fibre2Fashion News Desk (RR)
